1h Free Analyst Time
The iron drugs market is forecasted to grow by USD 4.58 billion during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the iron drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of iron deficiency globally, growing awareness about importance of iron in maintaining overall health, and growing geriatric population.
The iron drugs market is segmented as below:
By Product
- Oral drug
- IV drug
By Age Group
- Adult
- Pediatric
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the iron drugs market covers the following areas:
- Iron drugs market sizing
- Iron drugs market forecast
- Iron drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Age Group
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global iron drugs market: Abbott Laboratories, AbbVie Inc., Alinter Group Ltd., Alora Pharmaceuticals LLC, Breckenridge Pharmaceutical Inc., Covis Pharma GmbH, CSL Ltd., Daiichi Sankyo Co. Ltd., DSE Health Care Solutions Inc., GlaxoSmithKline PLC, Hiral Labs Ltd., McKesson Corp., NovaFerrum, Pharmacosmos AS, The Procter and Gamble Co., Reckitt Benckiser Group PLC, Rockwell Medical Inc., Sanofi SA, Shield Therapeutics PLC, and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of CKD dialysis centers in emerging economies."
According to the report, one of the major drivers for this market is the growing prevalence of iron deficiency globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Alinter Group Ltd.
- Alora Pharmaceuticals LLC
- Breckenridge Pharmaceutical Inc.
- Covis Pharma GmbH
- CSL Ltd.
- Daiichi Sankyo Co. Ltd.
- DSE Health Care Solutions Inc.
- GlaxoSmithKline Plc
- Hiral Labs Ltd.
- McKesson Corp.
- NovaFerrum
- Pharmacosmos AS
- The Procter and Gamble Co.
- Reckitt Benckiser Group Plc
- Rockwell Medical Inc.
- Sanofi SA
- Shield Therapeutics plc
- Zydus Lifesciences Ltd.
